Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay Dias

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Plos One|January 4, 2017
Claudin-Low Breast Cancer; Clinical & Pathological CharacteristicsKay Dias, Anna Dvorkin-Gheva, Robin M Hallett, et al.
Oncotarget|April 14, 2017
Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenograftsWilliam D Gwynne, Robin M Hallett, Adele Girgis-Gabardo, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Plos One|January 4, 2017
Claudin-Low Breast Cancer; Clinical & Pathological CharacteristicsKay Dias, Anna Dvorkin-Gheva, Robin M Hallett, et al.
Oncotarget|April 14, 2017
Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenograftsWilliam D Gwynne, Robin M Hallett, Adele Girgis-Gabardo, et al.
Pageof 1